B
Beta Bionics Inc
NASDAQ:BBNX
Beta Bionics Inc
NASDAQ:BBNX
Price:
10.97
USD
0.92%
Market Closed
Market Cap:
$482.9m
Relative Value
The Relative Value of one BBNX stock under the Base Case scenario is 15.51 USD. Compared to the current market price of 10.97 USD, Beta Bionics Inc is Undervalued by 29%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
BBNX
Relative Value
Base Case
15.51
USD
Undervaluation 29%
B
Multiples Across Competitors
BBNX Competitors Multiples
Beta Bionics Inc Competitors
Beta Bionics Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
B
|
Beta Bionics Inc
NASDAQ:BBNX
|
486.6m USD | 4.9 | -6.7 | -3.9 | -3.8 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
192B USD | 4.3 | 29.4 | 16.9 | 23.2 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
172.5B USD | 17.1 | 60.4 | 45.8 | 56.3 | |
| US |
|
Stryker Corp
NYSE:SYK
|
137.2B USD | 5.5 | 42.3 | 21.5 | 26 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
115.4B USD | 3.3 | 25 | 13.7 | 20 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
103.8B USD | 5.2 | 35.8 | 21 | 28.2 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
45.1B EUR | 1.9 | 21.2 | 11.8 | 16.6 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
49.8B USD | 8.2 | 46.4 | 25.6 | 28 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
47.7B USD | 11.1 | 45.1 | 32 | 35.4 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
46.7B USD | 2.1 | 26.6 | 10.4 | 17.5 | |
| US |
|
Resmed Inc
NYSE:RMD
|
36B USD | 6.7 | 24.2 | 17.1 | 19 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
